Choate represented Watchmaker Genomics, Inc. in obtaining a recommendation by U.S. Magistrate Judge Kathryn Starnella for a full dismissal of a patent infringement complaint filed against the company by biomodal Limited and Children’s Medical Center Corporation in the U.S. District Court for the District of Colorado. In biomodal Limited and Children’s Medical Center Corporation v. Watchmaker Genomics, Inc., No. 1:25-cv-03646-RMR-KAS (D. Colo.), the plaintiffs alleged that Watchmaker’s TAPS+ product infringed U.S. Patent Nos. 12,018,320 and 12,291,742 and sought damages and injunctive relief. The Magistrate Judge’s Report and Recommendation concludes that the asserted claims of both patents are directed to patent-ineligible subject matter under 35 U.S.C. § 101 and that the claims contain no inventive concept sufficient to satisfy the requirements for patent eligibility. Watchmaker Genomics is a developer and manufacturer of precision reagents for genomics and molecular diagnostics. Its DNA Library Prep Kit with TAPS+ uses bisulfite-free chemistry to enable simultaneous detection of DNA methylation and genetic variants from a single library. Subject to review by U.S. District Judge Regina M. Rodriguez, the recommendation, if adopted, will resolve the complaint in full. The Choate team was led by Michael Bunis, with additional support from Bryana McGillycuddy, Madison Garrett, and Maria Martinez. Read Watchmaker’s announcement here.